Supernus Pharmaceuticals Inc (SUPN) — Cash Flow Reinvestment Rate
Supernus Pharmaceuticals Inc (SUPN) has a Cash Flow Reinvestment Rate of 0.29x as of March 2026, reinvesting $19.22 Million (capex $0.00 plus investments $-19.22 Million) from operating cash flow of $66.52 Million. See SUPN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Supernus Pharmaceuticals Inc Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Supernus Pharmaceuticals Inc across 13 annual periods. For the full cash flow conversion analysis, see Supernus Pharmaceuticals Inc (SUPN) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Supernus Pharmaceuticals Inc (2009–2025)
Year-by-year capital reinvestment analysis for Supernus Pharmaceuticals Inc. See how financially flexible is Supernus Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 6.34x | $299.88 Million | $47.33 Million | $1.34 Million | ▲ +471.6% |
| 2024 | 1.11x | $190.59 Million | $171.95 Million | $725.00K | ▼ -57.0% |
| 2023 | 2.58x | $286.50 Million | $111.08 Million | $551.00K | ▲ +39.1% |
| 2022 | 1.85x | $216.66 Million | $116.83 Million | $412.00K | ▲ +6.7% |
| 2021 | 1.74x | $220.98 Million | $127.13 Million | $2.04 Million | ▼ -11.2% |
| 2020 | 1.96x | $270.98 Million | $138.40 Million | $3.45 Million | ▲ +76.0% |
| 2019 | 1.11x | $159.27 Million | $143.13 Million | $2.74 Million | ▼ -65.2% |
| 2018 | 3.20x | $412.67 Million | $128.99 Million | $844.00K | ▲ +387.3% |
| 2017 | 0.66x | $75.26 Million | $114.64 Million | $2.03 Million | ▲ +155.9% |
| 2016 | 0.26x | $17.14 Million | $66.81 Million | $1.60 Million | ▼ -71.0% |
| 2015 | 0.88x | $28.38 Million | $32.12 Million | $2.10 Million | ▲ +749.8% |
| 2014 | 0.10x | $804.00K | $7.73 Million | $593.00K | ▼ -61.6% |
| 2009 | 0.27x | $714.00K | $2.63 Million | $714.00K | — |